Next |
home / stock / alpmy / alpmy message board
Subject | By | Source | When |
---|---|---|---|
$ALPMY Lets go go go go... Up up and away we go. | SPORT19 | investorshub | 07/02/2023 2:22:09 PM |
bears and bulls | jtrenee89 | investorshub | 07/01/2023 10:34:52 PM |
Thoughts on where this is headed? | rdfdr1 | investorshub | 06/29/2023 4:31:26 PM |
bears and bulls | Sam0 | investorshub | 06/27/2023 3:56:52 AM |
$ALPMY and the shorts continue | johnsyn | investorshub | 06/22/2023 2:00:01 PM |
$ALPMY Looks pretty positive | rdfdr1 | investorshub | 06/21/2023 4:39:49 AM |
$ALPMY Price trading | johnsyn | investorshub | 06/16/2023 5:57:43 PM |
what does this mean? | SPORT19 | investorshub | 06/16/2023 9:39:58 AM |
$ALPMY When is this gonna take off? | mlkrborn | investorshub | 06/16/2023 1:05:33 AM |
$ALPMY MomentumIts trading last trade up | surf1944 | investorshub | 06/15/2023 3:31:19 PM |
$ALPMY The trading | kyrie717 | investorshub | 06/09/2023 12:33:03 PM |
$ALPMY oh yeah news for the day | johnsyn | investorshub | 06/07/2023 2:36:29 AM |
whytestocks: $ALPMY News Article - Astellas to Present Findings from Phase 3 Long-Term Safety Study | whytestocks | investorshangout | 10/12/2022 12:10:55 PM |
whytestocks: $ALPMY News Article - Here's What Recent News From the FDA Means for AstraZeneca | whytestocks | investorshangout | 08/20/2021 12:50:48 PM |
whytestocks: $ALPMY News Article - U.S. FDA Grants Regular Approval and Expands Indication for PADCE | whytestocks | investorshangout | 07/09/2021 6:35:50 PM |
SPORT19, thanks for the Astellas link. I | scoobey-do | investorshub | 01/02/2021 5:16:06 PM |
One week ago ProtoKinetix $CEO Clarence Smith posted | SPORT19 | investorshub | 01/02/2021 4:36:52 PM |
Astellas Innovation Management ($AIM) sounds like a partnership | SPORT19 | investorshub | 01/02/2021 4:35:34 PM |
Heres another MUST WATCH Astellas Institute of Regenerative | SPORT19 | investorshub | 01/02/2021 4:34:08 PM |
Astellas has undergone a MASSIVE expansion of its | SPORT19 | investorshub | 01/02/2021 4:33:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market:
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting PR Newswire 16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers TOKYO , May 13, 2024 /PRNe...
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor PR Newswire - 154,000 square-foot lab and office facility creates a central location for Astellas' West Coast cell and gene therapy research and bu...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology PR Newswire - Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR ® programs tar...